Add Company
Join Now

Belmar Pharma Solutions Revenue and Competitors

License our Company Data API

Golden, CO USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Belmar Pharma Solutions's estimated annual revenue is currently $42M per year.(i)
  • Belmar Pharma Solutions's estimated revenue per employee is $201,000

Employee Data

  • Belmar Pharma Solutions has 209 Employees.(i)
  • Belmar Pharma Solutions grew their employee count by 30% last year.

Belmar Pharma Solutions's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Product ManagementReveal Email/Phone
3
VP FinanceReveal Email/Phone
4
Director Marketing and Corporate CommunicationsReveal Email/Phone
5
Director Midwest OperationsReveal Email/Phone
6
Director Corporate Human ResourcesReveal Email/Phone
7
Clinical Director Women's HealthReveal Email/Phone
8
Director ComplianceReveal Email/Phone
9
Chief Information OfficerReveal Email/Phone
10
Chief Growth OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6M300%N/AN/A
#2
$9.6M48-6%N/AN/A
#3
$3.4M17-23%N/AN/A
#4
$195M1280%$121.4MN/A
#5
$5.8M29-19%N/AN/A
#6
$5.8M29-15%N/AN/A
#7
$5.8M2921%N/AN/A
#8
$4.2M42-11%$138MN/A
#9
$4.4M22-8%N/AN/A
#10
$19.9M9922%N/AN/A
Add Company

What Is Belmar Pharma Solutions?

Since 1985, Belmar Pharmacy has specialized in compounded oral, sublingual and topical dosage forms. What sets us apart is our unique BLAâ„¢ (Bioavailable Lymphatic Absorption) lipid matrix tablet system designed for oral HRT; our exclusive paraben-free, petroleum-free hormone cream base; and our outstanding customer service and value. Our goal is better patient outcomes, through quality compounding, and effective communication between practitioner, pharmacist and patient.

keywords:N/A

N/A

Total Funding

209

Number of Employees

$42M

Revenue (est)

30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$60.2M21821%N/A
#2
$42M2187%N/A
#3
$35.7M229-8%$261M
#4
$76.3M2570%N/A
#5
$52.1M2634%N/A